An atypical location for Malignant Triton Tumor – a case report

Main Article Content

Catarina Baía
https://orcid.org/0000-0002-0696-5212
Pedro Martins
https://orcid.org/0000-0003-2460-2746
Mário Serralva
Paula Pinto
https://orcid.org/0000-0003-2075-2827
Mariana Marques
https://orcid.org/0000-0002-0334-2028
José Carlos Silva
https://orcid.org/0000-0003-4286-5750
Maria João Cardoso
https://orcid.org/0000-0003-2459-1987
João Costa
https://orcid.org/0000-0002-9506-9662
Mariana Afonso
José Flávio Videira
https://orcid.org/0000-0002-6518-6198
Augusto Moreira
https://orcid.org/0000-0001-8692-3452
Joaquim Abreu de Sousa
https://orcid.org/0000-0002-4988-6987

Abstract

The authors report a case of a 52-years-old female patient, without personal or family history of genetic diseases, referred to our institution after an atypical gastrectomy with R2 resection for a gastric tumor suspected to be a GIST. Histopathological review was performed and a diagnosis of a high-grade soft tissue neoplasm with rhabdomyoblastic differentiation, compatible with malignant Triton tumor was rendered. After excluding residual disease, the patient was proposed to adjuvant chemotherapy. Two months later, a follow-up CT-scan showed a local recurrence, with no metastatic spread. After multidisciplinary team decision, she was submitted to R0 resection of the tumor consisting on total gastrectomy and splenectomy. Histopathological examination confirmed the recurrence of the malignant Triton tumor of gastric wall, with free margins. The patient was proposed for surveillance and currently there is no evidence of recurrent disease after 18-months.


This case highlights the importance of referral to a specialized sarcoma center in order to achieve a precise preoperative diagnosis and then a R0 resection. In our case, an R0 resection has resulted in the absence of disease recurrence during the 18-month. Furthermore, to the best of our knowledge, no malignant Triton tumor arising in the stomach has been published so far.

Article Details

How to Cite
Baía, C., Martins, P., Serralva, M., Pinto, P., Marques, M., Silva, J. C., Cardoso, M. J., Costa, J., Afonso, M., Videira, J. F., Moreira, A., & Sousa, J. A. de. (2023). An atypical location for Malignant Triton Tumor – a case report. Brazilian Journal of Case Reports, 4(1), 72–77. https://doi.org/10.52600/2763-583X.bjcr.2024.4.1.72-77
Section
Clinical Case Reports
Author Biographies

Catarina Baía, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Pedro Martins, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Mário Serralva, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Paula Pinto, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Mariana Marques, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

José Carlos Silva, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Maria João Cardoso, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

João Costa, Surgical Pathology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Pathology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal

Mariana Afonso, Surgical Pathology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Pathology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal

José Flávio Videira, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Augusto Moreira, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

Joaquim Abreu de Sousa, Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC)

Surgical Oncology Department, Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (P.CCC), Porto, Portugal.

References

Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021 Apr;113(2):70-84. doi: 10.32074/1591-951X-213. Epub 2020 Nov 3. PMID: 33179614; PMCID: PMC8167394.

Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med. 2006 Dec;130(12):1878-81. doi: 10.5858/2006-130-1878-MPNSTW. PMID: 17149968.

Woodruff JM, Chernik NL, Smith MC, Millett WB, Foote FW Jr. Peripheral nerve tumors with rhabdomyosarcomatous differentiation (malignant "Triton" tumors). Cancer. 1973 Aug;32(2):426-39. doi: 10.1002/1097-0142(197308)32:2<426::aid-cncr2820320221>3.0.co;2-w. PMID: 4198700.

Brooks JS, Freeman M, Enterline HT. Malignant "Triton" tumors. Natural history and immunohistochemistry of nine new cases with literature review. Cancer. 1985 Jun 1;55(11):2543-9. doi: 10.1002/1097-0142(19850601)55:11<2543::aid-cncr2820551105>3.0.co;2-4. PMID: 3922610.

Bins RB, Pinzon CE, da Silva Pereira LD, Bertuol M, Isolan PMBS, Takamatu EE. Malignant triton tumor of the kidney in a child: A case report. Int J Surg Case Rep. 2021 Aug;85:106252. doi: 10.1016/j.ijscr.2021.106252. Epub 2021 Jul 30. PMID: 34358962; PMCID: PMC8350500.

Daimaru Y, Hashimoto H, Enjoji M. Malignant "triton" tumors: a clinicopathologic and immunohistochemical study of nine cases. Hum Pathol. 1984 Aug;15(8):768-78. doi: 10.1016/s0046-8177(84)80169-0. PMID: 6235165.

McConnell YJ, Giacomantonio CA. Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associ-ated with improved survival. J Surg Oncol. 2012 Jul 1;106(1):51-6. doi: 10.1002/jso.23042. Epub 2012 Jan 17. PMID: 22253011.

Ellison DA, Corredor-Buchmann J, Parham DM, Jackson RJ. Malignant triton tumor presenting as a rectal mass in an 11-month-old. Pediatr Dev Pathol. 2005 Mar-Apr;8(2):235-9. doi: 10.1007/s10024-004-6068-4. Epub 2005 Mar 19. PMID: 15827834.

Herzberg J, Corradini GM, von Seydewitz C, Guraya SY, Strate T, Honarpisheh H. Malignant triton tumor of the rectum - A case report and review of the literature. Int J Surg Case Rep. 2020;76:517-521. doi: 10.1016/j.ijscr.2020.10.027. Epub 2020 Oct 9. PMID: 33207422; PMCID: PMC7596012.

Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Álava E, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F, Grignani G, Haas R, Hassan AB, Heck-er-Nolting S, Hindi N, Hohenberger P, Joensuu H, Jones RL, Jungels C, Jutte P, Kager L, Kasper B, Kawai A, Kopeckova K, Krákorová DA, Le Cesne A, Le Grange F, Legius E, Leithner A, Lopez-Pousa A, Martin-Broto J, Merimsky O, Messiou C, Mir O, Montemurro M, Morland B, Morosi C, Palmerini E, Pantaleo MA, Piana R, Piperno-Neumann S, Reichardt P, Rutkowski P, Safwat AA, Sangalli C, Sbaraglia M, Scheipl S, Schöffski P, Sleijfer S, Strauss D, Strauss S, Sundby Hall K, Trama A, Unk M, van de Sande MAJ, van der Graaf WTA, van Houdt WJ, Frebourg T, Casali PG, Stacchiotti S; ESMO Guidelines Committee, EURACAN and GENTURIS. Electronic address: clinicalguidelines@esmo.org. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Ann Oncol. 2021 Nov;32(11):1348-1365. doi: 10.1016/j.annonc.2021.07.006. Epub 2021 Jul 22. PMID: 34303806.

Strönisch A, Märdian S, Flörcken A. Centralized and Interdisciplinary Therapy Management in the Treatment of Sarcomas. Life (Basel). 2023 Apr 10;13(4):979. doi: 10.3390/life13040979. PMID: 37109507; PMCID: PMC10144040.

Blay JY, Honoré C, Stoeckle E, Meeus P, Jafari M, Gouin F, Anract P, Ferron G, Rochwerger A, Ropars M, Carrere S, Marchal F, Sirveaux F, Di Marco A, Le Nail LR, Guiramand J, Vaz G, Machiavello JC, Marco O, Causeret S, Gimbergues P, Fiorenza F, Chaigneau L, Guillemin F, Guilloit JM, Dujardin F, Spano JP, Ruzic JC, Michot A, Soibinet P, Bompas E, Chevreau C, Duffaud F, Rios M, Perrin C, Firmin N, Bertucci F, Le Pechoux C, Le Loarer F, Collard O, Karanian-Philippe M, Brahmi M, Dufresne A, Dupré A, Ducimetière F, Giraud A, Pérol D, Toulmonde M, Ray-Coquard I, Italiano A, Le Cesne A, Penel N, Bonvalot S; NETSARC/REPPS/RESOS and French Sarcoma Group–Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) Networks. Surgery in reference centers improves survival of sarcoma patients: a nationwide study. Ann Oncol. 2019 Jul 1;30(7):1143-1153. doi: 10.1093/annonc/mdz124. Erratum in: Ann Oncol. 2019 Jun 05;: PMID: 31081028; PMCID: PMC6637376.

Melo Mateus M, Catalão-Lopes M, Portugal R. Survival analysis of cancer patients in Portugal following the reference centre model implementation. Eur J Health Econ. 2023 Mar;24(2):157-168. doi: 10.1007/s10198-022-01461-x. Epub 2022 May 4. PMID: 35507197.

Ito Y, Kohashi K, Endo M, Yoshimoto M, Ishihara S, Toda Y, Susuki Y, Kawaguchi K, Furukawa H, Tateishi Y, Yamada Y, Kinoshita I, Mori T, Yamamoto H, Nakashima Y, Oda Y. Clinicopathological and prognostic significance of H3K27 methyl-ation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation. Virchows Arch. 2021 Dec;479(6):1233-1244. doi: 10.1007/s00428-021-03189-0. Epub 2021 Aug 25. PMID: 34432163.

Hornick JL, Nielsen GP. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhab-domyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma. Am J Surg Pathol. 2019 Oct;43(10):1323-1330. doi: 10.1097/PAS.

Otsuka H, Kohashi K, Yoshimoto M, Ishihara S, Toda Y, Yamada Y, Yamamoto H, Nakashima Y, Oda Y. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors. Pathol Res Pract. 2018 Mar;214(3):417-425. doi: 10.1016/j.prp.2017.12.015. Epub 2018 Jan 31. PMID: 29482987.

Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, Wasif N. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012 Mar;19(3):878-85. doi: 10.1245/s10434-011-1978-7. Epub 2011 Aug 23. PMID: 21861229.

Mussi CE, Daolio P, Cimino M, Giardina F, De Sanctis R, Morenghi E, Parafioriti A, Bartoli MS, Bastoni S, Cozzaglio L, Co-lombo P, Quagliuolo V. Atypical lipomatous tumors: should they be treated like other sarcoma or not? Surgical consideration from a bi-institutional experience. Ann Surg Oncol. 2014 Dec;21(13):4090-7. doi: 10.1245/s10434-014-3855-7. Epub 2014 Jun 25. PMID: 24962938.

Chen Y, Hao J, Yang Y, Yang J, Hao X. Tumor rupture predicts early metastasis and poor prognosis in stage III soft tissue sarcomas. World J Surg. 2011 May;35(5):1002-9. doi: 10.1007/s00268-011-0995-9. PMID: 21331475.

Hornick JL, Nielsen GP. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhab-domyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma. Am J Surg Pathol. 2019 Oct;43(10):1323-1330. doi: 10.1097/PAS.0000000000001290. PMID: 31107719.

Bottillo I, Ahlquist T, Brekke H, Danielsen SA, van den Berg E, Mertens F, Lothe RA, Dallapiccola B. Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. J Pathol. 2009 Apr;217(5):693-701. doi: 10.1002/path.2494. PMID: 19142971.